|
| 37097747 | Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms. | | 2023 |
| 38032827 | Hormonal Medications for Genitourinary Syndrome of Menopause. | | 2023 |
| 36780393 | Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long? | | 2023 |
| 37164492 | Intrapartum amnioinfusion reduces meconium aspiration syndrome and improves neonatal outcomes in patients with meconium-stained fluid: a systematic review and meta-analysis. | | 2023 |
| 36257374 | Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials. | Contraception | 2022 |
| 35998670 | Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer. | Menopause | 2022 |
| 35937447 | Incorporating Black women's perspectives into long-acting reversible contraception implementation. | F and S Reports | 2022 |
| 35921872 | Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women. | Contraception | 2022 |
| 35921870 | Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials. | Contraception | 2022 |
| 34636868 | Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause. | JAMA - Journal of the American Medical Association | 2021 |
| 31893960 | Pregnancy outcomes associated with an abnormal 50-g glucose screen during pregnancy: a systematic review and Meta-analysis. | Journal of Maternal-Fetal and Neonatal Medicine | 2021 |
| 31986539 | A Low 50-gram, 1-hour Glucose Challenge Test Value Predicts Neonatal Birth Weight Less than the 10th Percentile: A Systematic Review and Meta-Analysis. | American Journal of Perinatology | 2021 |
| 33950030 | Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. | Menopause | 2021 |
| 33785318 | Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system. | | 2021 |
| 34000251 | Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results. | Contraception | 2021 |
| 33570874 | Maintaining cognitive function in surgically menopausal women: the importance of estrogen. | Menopause | 2021 |
| 33518182 | Risks of Testosterone for Postmenopausal Women. | | 2021 |
| 33259782 | Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results. | | 2021 |
| 33433939 | Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies. | Int J Cancer | 2021 |
| 34668886 | Hormonal Contraception: Systemic Estrogen and Progestin Preparations. | Clinical Obstetrics and Gynecology | 2021 |
| 33110032 | The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy. | Menopause | 2020 |
| 31910280 | Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. | JAMA | 2020 |
| 32187132 | Hormone therapy and sarcopenia: implications for the prevention of frailty as women age. | Menopause | 2020 |
| 32345788 | The Women's Health Initiative trials of menopausal hormone therapy: lessons learned. | Menopause | 2020 |
| 32047026 | Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology. | Cancer Prev Res (Phila) | 2020 |
| 33048864 | Surgical menopause: health implications and hormonal management. | Menopause | 2020 |
| 32593537 | Does umbilical cord milking increase the risk of severe intraventricular hemorrhage in extreme preterm neonates? A multitreatment comparison. | American Journal of Obstetrics and Gynecology | 2020 |
| 32740481 | 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial. | Menopause | 2020 |
| 32852466 | In Reply. | Menopause | 2020 |
| 32621879 | Best Practices for Counseling Adolescents about the Etonogestrel Implant. | J Pediatr Adolesc Gynecol | 2020 |
| 32730575 | Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women. | JAMA Internal Medicine | 2020 |
| 33110039 | TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial. | Menopause | 2020 |
| 31498871 | Global Consensus Position Statement on the Use of Testosterone Therapy for Women. | J Clin Endocrinol Metab | 2019 |
| 31688572 | Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia. | Menopause | 2019 |
| 30407487 | Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study. | Am J Epidemiol | 2019 |
| 30489424 | Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms. | Menopause | 2019 |
| 30098845 | Vaginal estrogen: Underprescribed treatment for an underdiagnosed condition of menopausal women. | | 2019 |
| 30051202 | Reproductive health care across the lifecourse of the female cancer patient. | Supportive Care in Cancer | 2019 |
| 31503029 | Management of Menopause and the Role For Hormone Therapy. | Clinical Obstetrics and Gynecology | 2019 |
| 31176688 | Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use? | Contraception | 2019 |
| 31488288 | Global Consensus Position Statement on the Use of Testosterone Therapy for Women. | J Sex Med | 2019 |
| 31474158 | Global Consensus Position Statement on the Use of Testosterone Therapy for Women. | Climacteric | 2019 |
| 31484631 | Global Consensus Position Statement on the use of Testosterone Therapy for Women. | Maturitas | 2019 |
| 31453961 | Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices. | Menopause | 2019 |
| 31070673 | Abnormal Uterine Bleeding in Reproductive-Age Women. | JAMA - Journal of the American Medical Association | 2019 |
| 30954518 | Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis. | American Journal of Obstetrics and Gynecology | 2019 |
| 31259841 | Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of Menopause. | Clinical Obstetrics and Gynecology | 2019 |
| 30789455 | Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy. | Menopause | 2019 |
| 31364889 | Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms. | Climacteric | 2019 |
| 31499528 | Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial. | Ann Intern Med | 2019 |